human_insulin: profile and news
Diabetes gene therapy carried by 'bubbles' in the blood 16 May 2006
The ultrasonic pulse was similarly directed towards each rat's pancreas, and researchers later found significantly elevated levels of human insulin in the ... - New Scientist (subscription),
Fresh from the Pipeline: Inhaled human insulin May 4, 2006
In January 2006, human insulin inhalation powder (Exubera; Pfizer) was approved by the US FDA and the EMEA for the treatment of adult patients with diabetes ... - Nature.com (subscription),
Human Bone Marrow Mesenchymal Stem Cells Transfected with Human ... May 8, 2006
In order to obtain insulin-secreting cells, retrovirus vector pLNCX was used to transfer the human insulin gene into human bone marrow mesenchymal stem cells ... - Annals of Clinical & Laboratory Science (subscription),
Biocon to sell human insulin in Europe Apr 24, 2006
Biotech major Biocon is betting big on its recombinant human insulin in FY07 and is preparing a detailed European marketing plan for it. ... - Business Standard,
Understanding cloning May 15, 2006
For example, we insert the human insulin gene into bacteria, which then mass produce human insulin, which diabetic patients then use to treat their disease. ... - USA Today
SAFC launches insulin alternative to biomanufacturing May 15, 2006
So SAFC is targeting the industrial cell culture market with LONG R3IGF-I (LONGTMR3), a recombinant growth factor analogue of human insulin-like growth factor ... - In-PharmaTechnologist.com,
Little Difference Between Human Insulin And Faster-Acting Drugs Apr 18, 2006
Fast-acting artificial insulin drugs work just as well as regular human insulin, but it’s unclear how they could affect the health of people with diabetes ... - Health Behavior News Service
Your Drug Was Discontinued May 1, 2006
Lilly stopped selling the drug in March, and its last batch expired April 1. From now on, it will sell only synthetic human insulin produced by recombinant-DNA ... - TIME
Exubera: So Far No Evidence Available Of An Additional Therapeutic ... May 14, 2006
There is currently no evidence available that inhaled insulin (Exubera) in diabetes therapy shows advantages over short-acting human insulin or insulin ... - Medical News Today (press release),
Geron Announces Issuance of US Patent for Production of Insulin ... Apr 26, 2006
...with researchers at the University of Alberta, Edmonton, Geron scientists have also shown that these cells generate detectable human insulin upon glucose ... - International News Service,
Which type of insulin is better? Apr 23, 2006
For years, people with diabetes have used injectable human insulin to control their blood sugar. Ten years ago, a faster-acting ... - myDNA.com,
Tercica Reports First Quarter Financial Results; Conference Call ... May 9, 2006
The company's first product, Increlex or recombinant human insulin-like growth factor-1 (rhIGF-1), is the only therapy approved by the FDA for the long-term ... - Genetic Engineering News,
OutSystems Platform Supports Fast Roll-Out of US Biotech May 9, 2006
The company's first product, Increlex(TM) (mecasermin -rDNA origin- injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the ... - The Open Press (press release)
Exenatide Improves Hyperglycemia by Reducing Postprandial Glucose ... May 2, 2006
Clinical Endocrinologists (AACE). Insulin glargine is a human insulin analog produced by recombinant DNA technology. Since it is ... - DG News
Novo Nordisk Q1 EPS Edges Up; Sales Climb 23% On Strong Insulin ... Apr 28, 2006
...and 42% in local currencies. The main growth was sales of human insulin, primarily in China, India and Brazil. Sales in Japan were ... - Trading Markets,
Indian BT to ride on products Apr 23, 2006
...said. On the trends in the biotech sector, Avendus said that a sweltering growth is being seen in the human insulin market. The ... - Business Standard,
EU: The winners of the European Inventor of the Year 2006 awards May 3, 2006
...has developed production technologies for three other biopharmaceuticals, all based on Hansenula technology: Interferon alpha-2a, human insulin and Hirudin. ... - noticias.info,
Lilly Reports Q1 EPS of $.77, or 13% Growth Apr 20, 2006
50% insulin lispro injection (rDNA origin, Lilly) Humatrope(R) (somatropin of recombinant DNA origin, Lilly) Humulin(R) (human insulin of recombinant DNA origin ... - MSN Money
Tercica to Present at Baird's 27th Annual Growth Stock Conference ... May 4, 2006
The company's first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the ... - Genetic Engineering News,
More Stem Cells Are Better - Expanding Hematopoietic Stem Cells ... May 4, 2006
However, because HOXB4 protein is available in recombinant form (ie produced in cell culture, much like human insulin), it should be possible to treat HSCs ... - Medical News Today (press release),
Dynavax Scientist Receives 'European Inventor of the Year' Award ... May 4, 2006
...production and is used in a host of biopharmaceutical and biotech applications, including the production of Interferon alpha-2a, human insulin and Hirudin. ... - PR Newswire (press release),
